Skip to main content Accessibility help

The current status and future directions of efforts to create a global database for the outcomes of therapy for congenital heart disease

  • Jeffrey P. Jacobs (a1), Bohdan Maruszewski (a2), Christo I. Tchervenkov (a3), Francois G. Lacour-Gayet (a4), Marshall L. Jacobs (a5), David R. Clarke (a4), J. William Gaynor (a6), Thomas L. Spray (a6), Giovanni Stellin (a7), Martin J. Elliott (a8), Tjark Ebels (a9), Rodney C. G. Franklin (a10), Marie J. Béland (a3), Hiromi Kurosawa (a11), Vera D. Aiello (a12), Steven D. Colan (a13), Otto N. Krogmann (a14), Paul Weinberg (a6), Zdzislaw Tobota (a2), Rachel S. Dokholyan (a15), Eric D. Peterson (a15) and Constantine Mavroudis (a16)...


There are many reasons for seeking to create a global database with which to record the outcomes of therapy for congenital heart disease. Such a database can function as a tool to support a variety of purposes:


Corresponding author

Correspondence to: Jeffrey P. Jacobs MD, FACS, FACC, FCCP, The Congenital Heart Institute of Florida (CHIF) and University of South Florida (USF), Cardiac Surgical Associates (CSA), 603 Seventh Street South, Suite 450, St. Petersburg, FL 33701, USA. Tel: +1 727 822 6666; Fax: +1 727 821 5994; E-mail:; Web page:,


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed